u 77779 has been researched along with tallimustine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baraldi, PG; Beria, I; Caldarelli, M; Cozzi, P; Geroni, C; Marchini, S; Mongelli, N; Romagnoli, R | 1 |
| Woynarowski, JM | 1 |
1 review(s) available for u 77779 and tallimustine
| Article | Year |
|---|---|
Targeting critical regions in genomic DNA with AT-specific anticancer drugs.
Topics: Antineoplastic Agents; Base Sequence; Benzofurans; Binding Sites; Cyclohexanecarboxylic Acids; Cyclohexenes; Distamycins; DNA Damage; DNA, Neoplasm; Drug Design; Duocarmycins; Genome, Human; Humans; Indoles; Nitrogen Mustard Compounds; Tandem Repeat Sequences; Tumor Cells, Cultured; Urea | 2002 |
1 other study(ies) available for u 77779 and tallimustine
| Article | Year |
|---|---|
Cytotoxic alpha-halogenoacrylic derivatives of distamycin A and congeners.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Distamycins; Drug Screening Assays, Antitumor; Female; Glutathione; Guanidines; Humans; Inhibitory Concentration 50; Mice; Mice, Nude; Neoplasm Transplantation; Pyrroles; Structure-Activity Relationship; Transplantation, Heterologous | 2004 |